Parkinson'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Those who have been diagnosed with Parkinson's disease according to standard diagnostic criteria (2) Patients who have fully understood the explanatory document about this study and have given their consent to participate in the study (3) Patients who are scheduled to be hospitalized for short-term intensive rehabilitation at Tottori Medical Center (4) Patients who are receiving oral levodopa alone or in combination with other drugs (5) Patients with diurnal variation of motor symptoms and off hours more than once a day (with or without dyskinesia) (6) Adult males and females aged 20 years or older
Exclusion criteria
Exclusion criteria: (1) Subjects who are judged by the principal investigator or sub-investigator to have cognitive impairment that may affect the reporting of symptoms and functions (2) A person who has a musculoskeletal disorder that affects the assessment of motor symptoms of Parkinson's disease (3) The patient has an unstable comorbid condition (4) Patients with severe hearing loss who have difficulty in speech (5) Persons who use implantable medical devices such as cardiac pacemakers and defibrillators (6) A person who is judged by the principal investigator or subordinate investigator to be unsuitable for participation in the research for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of digital device (amue link) measurement results related to motor function | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of digital device (amue link) measurement results correlated with on-off time of symptom diary record, PDQ-39, CSQ-8J and MDS-UPDRS Comparison of digital device (amue link) measurement results before and after medication and rehabilitation | — |
Countries
Japan
Contacts
National Hospital Organization Tottori Medical Center Neurology